ORGANOGENESIS HOLDINGS INC. Secured Long-term Debt, Noncurrent
ORGANOGENESIS HOLDINGS INC. (ORGO) had Secured Long-term Debt, Noncurrent of $56.15 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:SecuredLongTermDebt · last filed 2025-02-27
- 2024-09-30: Secured Long-term Debt, Noncurrent $56.15M.
- 2024-06-30: Secured Long-term Debt, Noncurrent $57.73M.
- 2024-03-31: Secured Long-term Debt, Noncurrent $59.37M.
- 2023-12-31: Secured Long-term Debt, Noncurrent $60.74M.
| Period end | Secured Long-term Debt, Noncurrent |
|---|---|
| 2024-09-30 | $56.15M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $57.73M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $59.37M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $60.74M 10-K · filed 2025-02-27 |
| 2023-09-30 | $62.12M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $63.49M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $64.86M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $66.23M 10-K · filed 2024-02-29 |
| 2022-09-30 | $67.60M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $68.97M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $69.87M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $70.77M 10-K · filed 2023-03-01 |
| 2021-09-30 | $71.67M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $37.29M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $42.88M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $43.04M 10-K · filed 2022-03-01 |
| 2020-09-30 | $48.00M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $52.95M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $57.91M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $49.63M 10-K · filed 2021-03-16 |
| 2019-09-30 | $49.60M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |